Literature DB >> 23142217

MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3.

Xuguang Zheng1, Michael Chopp, Yong Lu, Benjamin Buller, Feng Jiang.   

Abstract

We tested invasion and angiogenesis related mRNA expression and miRNA profiles of glioma. Genes with mRNA expression that changed significantly were selected to predict possible miRNAs that regulate mRNA expression, and were then matched with miRNA results. NRP-2 with the matching miRNA miR-15b, and MMP-3 with the matching miRNA miR-152 were selected for further study. Luciferase activity assay confirmed that miR-15b and miR-152 attenuate expression of NRP-2 and MMP-3 protein by binding to NRP-2 and MMP-3 transcript, respectively. In vitro invasion assay data showed that miR-15b and miR-152 significantly decreased 9L cell invasiveness. In vitro tube formation assay data showed that miR-15b reduced tube formation. A preliminary pathway study indicated that miR-15b and miR-152 deactivated the MEK-ERK pathway via NRP-2 and MMP-3 in 9L cells, respectively.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23142217      PMCID: PMC3553580          DOI: 10.1016/j.canlet.2012.10.026

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  33 in total

Review 1.  Descriptive analysis and quantification of angiogenesis in human brain tumors.

Authors:  R D Folkerth
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Cancer: Out of air is not out of action.

Authors:  Donald P Bottaro; Lance A Liotta
Journal:  Nature       Date:  2003-06-05       Impact factor: 49.962

4.  Angiogenesis inhibitors: motivators of metastasis?

Authors:  Patricia S Steeg
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

5.  Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells.

Authors:  M T Canning; L M Postovit; S H Clarke; C H Graham
Journal:  Exp Cell Res       Date:  2001-07-01       Impact factor: 3.905

6.  Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2.

Authors:  P Kunkel; U Ulbricht; P Bohlen; M A Brockmann; R Fillbrandt; D Stavrou; M Westphal; K Lamszus
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

7.  The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis.

Authors:  M D Sternlicht; A Lochter; C J Sympson; B Huey; J P Rougier; J W Gray; D Pinkel; M J Bissell; Z Werb
Journal:  Cell       Date:  1999-07-23       Impact factor: 41.582

8.  Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption.

Authors:  J L Rubenstein; J Kim; T Ozawa; M Zhang; M Westphal; D F Deen; M A Shuman
Journal:  Neoplasia       Date:  2000 Jul-Aug       Impact factor: 5.715

Review 9.  microRNAs in cancer management.

Authors:  Yi W Kong; David Ferland-McCollough; Thomas J Jackson; Martin Bushell
Journal:  Lancet Oncol       Date:  2012-06       Impact factor: 41.316

10.  Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma.

Authors:  Eugene S Kim; Anna Serur; Jianzhong Huang; Christina A Manley; Kimberly W McCrudden; Jason S Frischer; Samuel Z Soffer; Laurence Ring; Tamara New; Stephanie Zabski; John S Rudge; Jocelyn Holash; George D Yancopoulos; Jessica J Kandel; Darrell J Yamashiro
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

View more
  79 in total

1.  ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor-initiating cells.

Authors:  Susobhan Sarkar; Franz J Zemp; Donna Senger; Stephen M Robbins; V Wee Yong
Journal:  Neuro Oncol       Date:  2015-02-01       Impact factor: 12.300

Review 2.  Glioblastoma: exosome and microRNA as novel diagnosis biomarkers.

Authors:  L Saadatpour; E Fadaee; S Fadaei; R Nassiri Mansour; M Mohammadi; S M Mousavi; M Goodarzi; J Verdi; H Mirzaei
Journal:  Cancer Gene Ther       Date:  2016-11-11       Impact factor: 5.987

3.  Decreased Expression of miR-15b in Human Gliomas is Associated with Poor Prognosis.

Authors:  Guan Sun; Shushan Yan; Lei Shi; Zhengqiang Wan; Nan Jiang; Min Li; Jun Guo
Journal:  Cancer Biother Radiopharm       Date:  2015-03-26       Impact factor: 3.099

Review 4.  SASP regulation by noncoding RNA.

Authors:  Amaresh C Panda; Kotb Abdelmohsen; Myriam Gorospe
Journal:  Mech Ageing Dev       Date:  2017-05-11       Impact factor: 5.432

5.  Mir-152 inhibits cell proliferation and colony formation of CD133(+) liver cancer stem cells by targeting KIT.

Authors:  Haili Huang; Min Hu; Peng Li; Caijie Lu; Mingyi Li
Journal:  Tumour Biol       Date:  2014-10-15

6.  Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma.

Authors:  Feng Zhi; Naiyuan Shao; Rong Wang; Danni Deng; Lian Xue; Qiang Wang; Yi Zhang; Yimin Shi; Xiwei Xia; Suinuan Wang; Qing Lan; Yilin Yang
Journal:  Neuro Oncol       Date:  2014-08-18       Impact factor: 12.300

7.  miR-15b Inhibits the Progression of Glioblastoma Cells Through Targeting Insulin-like Growth Factor Receptor 1.

Authors:  Jian Wang; Huaqiang Liu; Lin Tian; Fachen Wang; Liangbo Han; Wei Zhang; Yun-An Bai
Journal:  Horm Cancer       Date:  2016-11-28       Impact factor: 3.869

8.  Expression and clinical significance of microRNA-152 in supragalottic laryngeal carcinoma.

Authors:  Yan Song; Yuan Tian; Wei-Liang Bai; Xiu-Lan Ma
Journal:  Tumour Biol       Date:  2014-08-06

9.  miR-15b/16-2 deletion promotes B-cell malignancies.

Authors:  Francesca Lovat; Matteo Fassan; Pierluigi Gasparini; Lara Rizzotto; Luciano Cascione; Marco Pizzi; Caterina Vicentini; Veronica Balatti; Dario Palmieri; Stefan Costinean; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-31       Impact factor: 11.205

10.  Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer.

Authors:  Jian Li; Yuxiang Chen; Xiong Guo; Ling Zhou; Zeming Jia; Yaping Tang; Ling Lin; Weidong Liu; Caiping Ren
Journal:  Tumour Biol       Date:  2016-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.